Teva Pharmaceutical Industries has reached an agreement with workers at an inhaler plant in Jerusalem about when the facility will be shut down.
The company recently announced a major global restructuring plan that involves laying off 14,000 workers and closing dozens of manufacturing facilities. The news triggered unrest among worker unions in Israel, the company’s home country.
Now, Teva has agreed to lay off 60 workers at the inhaler facility by the end of February. The remaining 180 employees will stay on board until the plant is closed in December 2019.
Teva will also close 20 to 25 other manufacturing facilities over the next two years.